VS
Virendra Shivram Nachane
About Virendra Shivram Nachane
Data last updated:
Virendra Shivram Nachane has 12 years in corporate governance. Holds Director role. Currently with 1 company, including Matilda Pharmaceuticals (India) Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Matilda Pharmaceuticals (India) Private Limited at ₹1.15 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Matilda Pharmaceuticals (India) Private Limited U24200PN2014PTC151822 | Director | 15 Jul 2014 | 2014 | ₹1.15 Cr (FY 2025) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Virendra Shivram Nachane
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Virendra Shivram Nachane
Virendra Shivram Nachane has 12 years in corporate governance. Holds Director role. Currently with 1 company, including Matilda Pharmaceuticals (India) Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Matilda Pharmaceuticals (India) Private Limited at ₹1.15 Cr (FY 2025).
Virendra Shivram Nachane is associated with 1 company as Director, including Matilda Pharmaceuticals (India) Private Limited (₹1.15 Cr).
Virendra Shivram Nachane has expertise in General Business.
Virendra Shivram Nachane has 12 years in corporate governance.
By reported revenue, the largest current company of Virendra Shivram Nachane is Matilda Pharmaceuticals (India) Private Limited, with revenue of ₹1.15 Cr (FY 2025).
Virendra Shivram Nachane currently holds positions at 1 company: Matilda Pharmaceuticals (India) Private Limited (₹1.15 Cr).